MPLT
MapLight Therapeutics, Inc.
Key Financials
Net Income
$-161152000
↓ 107.7%
Operating Income
$-169083000
↓ 103.8%
EPS (Diluted)
$-18.56
↑ 82.4%
Total Assets
$479.5M
↑ 250.2%
Total Liabilities
$21.1M
↓ 2.7%
Cash & Equivalents
$46.7M
↑ 22.2%
Shareholders' Equity
$458.4M
↑ 336.7%
Operating Cash Flow
$-138137000.00
↓ 75.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| SCHEDULE 13D/A | 8/3/2026 | View on SEC |
| 144 | 8/3/2026 | View on SEC |
| SCHEDULE 13D/A | 7/31/2026 | View on SEC |
| 144 | 7/30/2026 | View on SEC |
| 4 | 7/30/2026 | View on SEC |
| 4 | 7/28/2026 | View on SEC |
| 8-K | 7/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MPLT |
| Company Name | MapLight Therapeutics, Inc. |
| CIK | 1770069 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-839-4360 |